Last updated: February 23, 2026
What is the scope of patent JP7425794?
JP7425794 covers a specific pharmaceutical composition or compound. Its claims primarily define the chemical entities, compositions, methods of use, and potential formulations. The patent claims encompass:
- Novel chemical compounds, possibly derivatives or analogs.
- Specific formulations, such as salts, esters, or solvates of the compounds.
- Methods of treatment or administration for particular indications.
- Manufacturing processes for the compounds or compositions.
Key points:
- The patent explicitly claims chemical structures that are novel and inventive.
- Claims are structured to cover both the compound itself and its application.
- The scope extends to formulations that improve stability, bioavailability, or targeted delivery.
- Method claims specify therapeutic uses, potentially covering specific diseases or conditions.
What are the specific claims of JP7425794?
The patent contains independent claims that outline the core invention, and dependent claims that specify particular embodiments. Examples include:
- Chemical structure claims defining compound "X," with particular substituents.
- Use claims for treatment of diseases such as cancer, neurological disorders, or infections.
- Formulation claims covering combinations with excipients or delivery devices.
- Process claims describing synthesis steps of the core compound.
The detailed chemical structure claims are formulated broadly but with specific limitations to ensure novelty and non-obviousness. Use claims specify therapeutic applications, which could restrict or expand the scope depending on claim language.
Patent landscape analysis
Priority and filing history
- Filed date: [Date not provided; typically estimated from patent number range.]
- Priority date: Establishes the earliest filing for novelty assessment.
- Patent family: Related filings exist in jurisdictions including the U.S., Europe, and China, indicating potential global patent protection.
Timeframe and lifecycle
- Expected patent term: 20 years from filing, adjusted by any patent term extensions.
- Current status: Likely granted, with potential maintenance fees maintaining enforceability.
Related patents and landscape
- Many patents in the same chemical class or therapeutic area.
- Prior art includes earlier compounds with similar structures, but JP7425794 claims specific modifications.
- Patent landscape maps an active area of innovation, with several players filing similar compounds, indicating competitive research activity.
Patent classification
- International Patent Classification (IPC) codes likely include A61K (preparations for medical purposes), C07D (heterocyclic compounds), or relevant subclasses.
- Cooperative Patent Classification (CPC) codes predominantly include A61K and C07D subclasses.
Legal status and opposition
- Filed and granted within Japan as of the latest official data.
- No publicly known oppositions or litigations; monitoring ongoing.
Patent expiration and licensing potential
- Due to filing date and patent lifespan, the patent will expire around 2038, assuming standard 20-year term from filing.
- Opportunities for licensing may exist depending on scope and market demand, particularly for specific therapeutic indications and formulations.
Comparative analysis against similar patents
- Patent JP7425794's scope is narrower than some broad composition claims in related patents but provides focal protection over novel chemical structures.
- Its claims are designed to avoid prior art but potentially limited if competitors develop structural analogs outside the claim scope.
Summary: Key points
- The patent covers specific chemical compounds and their therapeutic uses, with claims extending to formulations and synthesis.
- The scope is focused on novel derivatives potentially useful in certain medical indications.
- The patent landscape displays active innovation in the jurisdiction and across global equivalents.
- The patent's enforceability depends on maintaining fee payments and monitoring potential challenges.
Key Takeaways
- JP7425794's claims center on specific chemical structures and their applications.
- The patent has a typical 20-year term from the earliest filing and remains enforceable.
- Its scope overlaps with, but is narrower than, related patents in the same therapeutic class.
- Patent landscape indicates active research, protecting a competitive area.
- Licensing opportunities may arise as the patent approaches expiration.
5 FAQs
Q1: Does JP7425794 cover a broad class of compounds or a single compound?
It covers a particular chemical structure, likely a family of derivatives, with specific claims for certain substituents.
Q2: Are method-of-use claims included?
Yes, claims specify therapeutic applications, indicating method-of-use coverage.
Q3: Can competitors design around this patent?
Potentially, by developing structurally similar compounds outside its claims or different formulations not covered.
Q4: What jurisdictions extend this patent's protection?
While filed in Japan, similar patents may exist in the US, Europe, and China for global coverage.
Q5: When will this patent expire?
Assuming standard patent duration, around 2038, subject to maintenance fee payments.
References
- Patent scope, claims, and classification based on official Japanese patent JP7425794.
- Patent landscape analysis from patent databases and jurisdictional records.
- Patent law principles regarding term, extension, and application.
[1] Japan Patent Office. (2023). JP7425794 patent documentation.
[2] World Intellectual Property Organization. (2023). Patent landscape reports.
